Stocklytics Platform
Asset logo for symbol LMAT
LeMaitre Vascular
LMAT76
$86.20arrow_drop_up1.04%$0.89
High Quality
High Growth
Asset logo for symbol LMAT
LMAT76

$86.20

arrow_drop_up1.04%
Key Stats
Open$86.35
Prev. Close$86.48
EPS1.51
Next Earnings DateAug 1, 2024
LOWHIGH
Day Range84.54
87.35
52 Week Range44.27
88.75
Ratios
EPS1.51
Fundamentals
Industry average yield2.83%
Last Dividend pay dateMay 30, 2024

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell
Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

LMATarrow_drop_down1.35%
US Healthcare Sectorarrow_drop_down1.06%
US Marketarrow_drop_down1.15%
warning
LMAT / Market
LMAT lose to the US Market which returned -1.15% over the last twenty four hours.
warning
LMAT / Healthcare Sector
LMAT lose to the US Healthcare sector which returned -1.06% over the last twenty four hours.

LeMaitre Vascular (LMAT) Statistics

LeMaitre Vascular Inc (LMAT) is a company that specializes in the development and manufacturing of medical devices for the treatment of peripheral vascular disease. The company's stock has been performing well in recent years, with strong revenue growth and a positive profit margin. In terms of valuation metrics, LMAT has a price-to-earnings ratio of 45.32, which is slightly higher than the industry average. This indicates that investors are willing to pay a premium for the company's stock. Additionally, LMAT has a price-to-sales ratio of 5.38, indicating that the company's stock is trading at a premium relative to its sales.

One of the key fundamentals of LMAT is its strong gross profit margin, which currently stands at 70.32%. This indicates that the company is generating a significant amount of revenue from its sales. In addition, LMAT has a low level of total debt, with a debt-to-equity ratio of 0.13. This indicates that the company has a strong balance sheet and is not heavily reliant on debt financing. Another important metric to consider is LMAT's enterprise to EBITDA ratio, which currently stands at 23.94. This indicates that the company's stock is trading at a premium relative to its earnings before interest, taxes, depreciation, and amortization.

add LeMaitre Vascular  to watchlist

Keep an eye on LeMaitre Vascular

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
How has LeMaitre Vascular (LMAT) stock's performance compared to its sector and the market over the past year?

Over the past year, LeMaitre Vascular (LMAT) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 25.12%, LeMaitre Vascular has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 50.49%, it has fallen short of the market average. This comparison highlights LeMaitre Vascular 's performance relative to both its sector and the overall market over the last year.

help
What is the PE ratio of LeMaitre Vascular (LMAT) stock?

The PE (Price to Earnings) ratio of LeMaitre Vascular (LMAT) is currently 57.09. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.

help
What is the EPS of LeMaitre Vascular (LMAT) stock?

The Earnings Per Share (EPS) for LeMaitre Vascular (LMAT), calculated on a diluted basis, is $1.51. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.

help
What is the operating margin of LeMaitre Vascular (LMAT) stock?

The operating margin for LeMaitre Vascular (LMAT) is 22.2%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.

help
What is the EBITDA of LeMaitre Vascular (LMAT) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of LeMaitre Vascular (LMAT) is $52.55M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.

help
How much debt does LeMaitre Vascular (LMAT) have?

LeMaitre Vascular (LMAT) has a total debt of $18.88M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$7.71M.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level